Torrent Group is planning to expand its Kadi based pharma facility and set up
a green field project at upcoming Dahej SEZ in Gujarat.
Torrent Pharma, a part of Torrent Group, has reportedly approached the
regulatory authorities to expand its existing Indrad facility at Kadi in Mehsana
district. At Indrad, the company has capacity to manufacture 6,000 million
tablets, capsules and vials and 15,000 kg of bulk drugs per annum.
Moreover, the company has received approval from the Dahej SEZ approval
committee for setting up a formulation and bulk drugs manufacturing facility at
the SEZ.
Civil work is likely to commence shortly at its 1.64 lakh sq mtrs land at SEZ
where it is planning to invest Rs 300 crore for pharma unit.